“…Given the difference in ion size of Bi III ,t heseb ond lengths correspond wellw ith analogous MÀOb onds in the 3hydroxyflavonolate complexes with Mn II (2.1274(16) )a nd Fe III (1.955(7) ), [31] and are shorter than the equivalent bond in the Pb II 3-hydroxyflavonolatec omplex (2.2270 (19) ). [32] The carbonyl oxygens of the flavonolate ligands in 1b also coordinate to the Bi III centre, having longerB i ÀO(=C) bond lengths in the range of 2.476(3)-2.704(2) .B oth of the anionic and coordinative BiÀOb ond lengths in 1b are consistentw ith the range of reported BiÀOb ond distances. [33] The formation of five-membered O,O-chelate rings by the flavonolate ligands coordinating to the Bi III centre is consistent with the structures of other metal-flavonolate complexes.…”
Section: X-ray Crystallographysupporting
confidence: 61%
“…[24a, 25, 37] The hydroxylate BiÀOb ondl engths of 2.293(3) (Bi(1)ÀO(1)) and 2.252(3) (Bi(1)ÀO(3)) are longer than the analogous bonds in the tris-substituted flavonolate complex 6b (2.182(3)-2.207(3) ), and longer than the hydroxylate PbÀOb ond in the 3-hydroxyflavonolate Pb II complex. [32] The coordinating DMSO molecule makes as ignificantly longer interaction (2.618(3) )t ot he Bi III centre through the O(5) oxygen atom compared to the two coordinating BiÀO=Ci nteractions made by the carbonyl oxygens of the flavonolate ligands (2.556(3) and 2.536(3) ). Complexes 1c, 2c,a nd 5c also crystallised with as ingle coordinatings olvent molecule (DMSOo rTHF) and show isostructural geometries to 6c•(DMSO).…”
Section: X-ray Crystallographymentioning
confidence: 99%
“…[30a, 31-32] The three flavonolate O-Bi-O bite angles in 1b are in the range of 66.49(8)-69.33(8)8 which is similart ot he Pb II 3-hydroxyflavonolate complex( 68.14(7)8)p reviously described. [32] The carbonyl C=Od istances of the 3-hydroxyflavonolate ligandsi n1b are in the range of 1.254(4)-1.262 (4) which are elongated compared to free 3-hydroxyflavone (1.232(3) ). [34] However,t he hydroxylate CÀOb ond lengths (1.327(4)-1.336(4) )a re shorter compared to the free flavonol (1.357(3) ).…”
A series of homoleptic and heteroleptic bismuth(III) flavonolate complexes derived from six flavonols of varying substitution have been synthesised and structurally characterised. The complexes were evaluated for antibacterial activity towards several problematic Gram‐positive (Staphylococcus aureus, methicillin‐resistant Staphylococcus aureus (MRSA), and vancomycin‐resistant Enterococcus (VRE)) and Gram‐negative (Escherichia coli, Pseudomonas aeruginosa) bacteria. The cell viability of COS‐7 (monkey kidney) cells treated with the bismuth flavonolates was also studied to determine the effect of the complexes on mammalian cells. The heteroleptic complexes [BiPh(L)2] (in which L=flavonolate) showed good antibacterial activity towards all of the bacteria but reduced COS‐7 cell viability in a concentration‐dependent manner. The homoleptic complexes [Bi(L)3] exhibited activity towards the Gram‐positive bacteria and showed low toxicity towards the mammalian cell line. Bismuth uptake studies in VRE and COS‐7 cells treated with the bismuth flavonolate complexes indicated that Bi accumulation is influenced by both the substitution of the flavonolate ligands and the degree of substitution at the bismuth centre.
“…Given the difference in ion size of Bi III ,t heseb ond lengths correspond wellw ith analogous MÀOb onds in the 3hydroxyflavonolate complexes with Mn II (2.1274(16) )a nd Fe III (1.955(7) ), [31] and are shorter than the equivalent bond in the Pb II 3-hydroxyflavonolatec omplex (2.2270 (19) ). [32] The carbonyl oxygens of the flavonolate ligands in 1b also coordinate to the Bi III centre, having longerB i ÀO(=C) bond lengths in the range of 2.476(3)-2.704(2) .B oth of the anionic and coordinative BiÀOb ond lengths in 1b are consistentw ith the range of reported BiÀOb ond distances. [33] The formation of five-membered O,O-chelate rings by the flavonolate ligands coordinating to the Bi III centre is consistent with the structures of other metal-flavonolate complexes.…”
Section: X-ray Crystallographysupporting
confidence: 61%
“…[24a, 25, 37] The hydroxylate BiÀOb ondl engths of 2.293(3) (Bi(1)ÀO(1)) and 2.252(3) (Bi(1)ÀO(3)) are longer than the analogous bonds in the tris-substituted flavonolate complex 6b (2.182(3)-2.207(3) ), and longer than the hydroxylate PbÀOb ond in the 3-hydroxyflavonolate Pb II complex. [32] The coordinating DMSO molecule makes as ignificantly longer interaction (2.618(3) )t ot he Bi III centre through the O(5) oxygen atom compared to the two coordinating BiÀO=Ci nteractions made by the carbonyl oxygens of the flavonolate ligands (2.556(3) and 2.536(3) ). Complexes 1c, 2c,a nd 5c also crystallised with as ingle coordinatings olvent molecule (DMSOo rTHF) and show isostructural geometries to 6c•(DMSO).…”
Section: X-ray Crystallographymentioning
confidence: 99%
“…[30a, 31-32] The three flavonolate O-Bi-O bite angles in 1b are in the range of 66.49(8)-69.33(8)8 which is similart ot he Pb II 3-hydroxyflavonolate complex( 68.14(7)8)p reviously described. [32] The carbonyl C=Od istances of the 3-hydroxyflavonolate ligandsi n1b are in the range of 1.254(4)-1.262 (4) which are elongated compared to free 3-hydroxyflavone (1.232(3) ). [34] However,t he hydroxylate CÀOb ond lengths (1.327(4)-1.336(4) )a re shorter compared to the free flavonol (1.357(3) ).…”
A series of homoleptic and heteroleptic bismuth(III) flavonolate complexes derived from six flavonols of varying substitution have been synthesised and structurally characterised. The complexes were evaluated for antibacterial activity towards several problematic Gram‐positive (Staphylococcus aureus, methicillin‐resistant Staphylococcus aureus (MRSA), and vancomycin‐resistant Enterococcus (VRE)) and Gram‐negative (Escherichia coli, Pseudomonas aeruginosa) bacteria. The cell viability of COS‐7 (monkey kidney) cells treated with the bismuth flavonolates was also studied to determine the effect of the complexes on mammalian cells. The heteroleptic complexes [BiPh(L)2] (in which L=flavonolate) showed good antibacterial activity towards all of the bacteria but reduced COS‐7 cell viability in a concentration‐dependent manner. The homoleptic complexes [Bi(L)3] exhibited activity towards the Gram‐positive bacteria and showed low toxicity towards the mammalian cell line. Bismuth uptake studies in VRE and COS‐7 cells treated with the bismuth flavonolate complexes indicated that Bi accumulation is influenced by both the substitution of the flavonolate ligands and the degree of substitution at the bismuth centre.
“…20 The oxygenation of 3HF was also studied with the use of photosensitizers, and the same products (SA + CO) were obtained. 21 The photooxygenation of some metal complexes with (anionic) 3HF ligand also yields SA, releasing CO. [22][23][24] The direct as well as the photosensitized oxygenation of avonols, the natural 3HF derivatives, lead to the respective SA-s. 25,26 In deaerated solutions, a photorearrangement takes place resulting in 3-hydroxy-3-phenyl-indan-1,2-dione (IN). 27 These reactions are of importance in the characterization of the photostability of 3HF-based uorescent probes.…”
The photooxygenation of 3-hydroxyflavone (3HF) into O-benzoyl salicylic acid and the photorearrangement of 3HF into 3-hydroxy-3-phenyl-indane-1,2-dione have been studied using theoretical calculations. These are the main photodegradation reactions of this versatile fluorescent probe which exhibits excited state intramolecular proton transfer (ESIPT). The Gibbs free energies for the ground/excited state species were computed at the DFT/TD-DFT level of theory. The calculations on the direct photooxygenation (T 1 state phototautomeric form of 3HF +
“…Examples include compounds that exhibit anticancer (M = Ru II ; Kurzwernhart et al, 2013;Saraf et al, 2014), antidiabetic (M = Zn II ; Vijayaraghavan et al, 2012), and antioxidant (Pieniazek et al, 2014;de Souza & de Giovani, 2004) properties. Radiopharmaceuticals (M = Re I ; Schutte et al, 2011) and light-induced CO releasing molecules (M = Zn II ; Grubel et al, 2011Grubel et al, , 2013 have also been developed based on metal-flavonolate structures. The 3-hydroxyflavonolate ligand typically coordinates in a bidentate Recently, we reported the first example of bridging flavonolate ligation in a dinuclear zinc complex using an extended flavonol ligand (Popova et al, 2017).…”
Metal-flavonolate compounds are of significant current interest as synthetic models for quercetinase enzymes and as bioactive compounds of importance to human health. Zinc-3-hydroxyflavonolate compounds, including those of quercetin, kampferol, and morin, generally exhibit bidentate coordination to a single Zn center. The bipyridine-ligated zinc-flavonolate compound reported herein, namely bis(μ-4-oxo-2-phenyl-4H-chromen-3-olato)-κO:O,O;κO,O:O-bis[(2,2'-bipyridine-κN,N')zinc(II)] bis(perchlorate), {[Zn(CHO)(CHN)](ClO)}, (1), provides an unusual example of bridging 3-hydroxyflavonolate ligation in a dinuclear metal complex. The symmetry-related Zn centers of (1) exhibit a distorted octahedral geometry, with weak coordination of a perchlorate anion trans to the bridging deprotonated O atom of the flavonolate ligand. Variable-concentration conductivity measurements provide evidence that, when (1) is dissolved in CHCN, the complex dissociates into monomers. H NMR resonances for (1) dissolved in d-DMSO were assigned via HMQC to the H atoms of the flavonolate and bipyridine ligands. In CHCN, (1) undergoes quantitative visible-light-induced CO release with a quantum yield [0.004 (1)] similar to that exhibited by other mononuclear zinc-3-hydroxyflavonolate complexes. Mass spectroscopic identification of the [(bpy)Zn(O-benzoylsalicylate)] ion provides evidence of CO release from the flavonol and of ligand exchange at the Zn center.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.